Financial News
FDA chief tells reporter 'move on' when pressed on Biogen Alzheimer's drug approval
July 14, 2021 at 16:15 PM EDT
Acting FDA Commissioner Dr. Janet Woodcock pushed back against questions from a journalist about the approval of Biogen's Alzheimer's medication, Aduhelm.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
